Dehydration and diarrhea occur together as the body loses essential fluids. Learn why children and older adults are more ...

Paystand today announced that it is a Gold level sponsor of SuiteWorld 2024, Oracle NetSuite's largest celebration for customers and partners taking place September 9-12, 2024 at the Caesars Forum in ...

BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced it will host Trending Topics in ADME & Drug Development Research, a ...

Earlier in his career, Mr. Russo worked in roles of increasing responsibility within Merck & Co., Inc.'s manufacturing ... from the University of Chicago Booth School of Business, and he is ...

Winners will be featured in the VETTY Awards booth inside the Expo Hall and receive an invitation ... Kit" by Boehringer ...

Merck & Co.’s best-selling drug Keytruda helped women with a hard-to-treat form of breast cancer live longer, according to the first study to show such a benefit in these patients. After five ...

In an email, the company pointed out that the majority of patients in LITESPARK-005 received Welireg as their third or fourth-line treatment (87.4%) after being treated with PD-1/L1 inhibitor and ...

In 2021, the FDA blasted Merck for using a premature endpoint to pursue a Keytruda approval in early-stage triple-negative breast cancer (TNBC). Now, the PD-1 inhibitor has gold-standard overall ...

This marks Keytruda's first approval for the given indication. Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.